Patient Leaflet Updated 26-Mar-2026 | Aguettant Ltd
Baclofen Aguettant 0.5mg/ml solution for infusion
Baclofen Aguettant 0.5 mg/ml
solution for infusion
Baclofen Aguettant 0.5 mg/ml, solution for infusion
baclofen
1. What Baclofen Aguettant is and what it is used for
2. What you need to know before you use Baclofen Aguettant
3. How to use Baclofen Aguettant
4. Possible side effects
5. How to store Baclofen Aguettant
6. Contents of the pack and other information
Baclofen Aguettant belongs to a group of medicines called muscle relaxants. Baclofen Aguettant is administered by injection into the spinal canal directly into the spinal fluid (intrathecal injection) and relieves severe muscle rigidity (spasticity).
Baclofen Aguettant is used to treat severe, long-lasting muscle tension (spasticity) occurring in various illnesses, such as:
Baclofen Aguettant is used in adults and children aged 4 years and above. It is used when other orally taken medicines, including baclofen, have been unsuccessful or caused unacceptable side effects.
Talk to your doctor or pharmacist before using Baclofen Aguettant
If the answer to any of this list of questions is YES, tell your doctor or nurse because Baclofen Aguettant may not be the right medicine for you.
Tell your doctor immediately if you get any of these symptoms during treatment with Baclofen Aguettant:
Baclofen Aguettant is not recommended for children under 4 years. Children should be of sufficient body mass to accommodate the implantable pump for chronic infusion. There is very limited clinical data regarding the safety and efficacy of the use of Baclofen Aguettant in children under the age of four year.
In studies, elderly patients treated with Baclofen Aguettant had no specific problems. However, experience with oral baclofen administration shows that this patient group is more likely to experience side effects. Elderly patients should therefore be carefully monitored for the occurrence of side effects.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Some medicines can interfere with your treatment. Remind your doctor or nurse if you are taking any of the following:
Avoid drinking alcohol during treatment with Baclofen Aguettant as this may lead to an undesirable intensification or unpredictable change in the effects of the medicine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Pregnancy
There is limited experience on the use of intrathecal baclofen during pregnancy. Oral baclofen should not be used during pregnancy unless absolutely necessary, due to cases of malformations (of the central nervous system, bone anomalies, omphalocele (malformation of the abdominal wall)) reported in children of mothers who have received this treatment. If oral baclofen is used until delivery, a withdrawal syndrome may occur in the newborn.
The newborn may experience convulsions and other symptoms associated with abrupt cessation of treatment immediately after delivery (see If treatment with Baclofen Aguettant is interrupted). This syndrome may be delayed for several days after birth. If you take this medicine during pregnancy, you should be monitored and treated accordingly.
Baclofen Aguettant should not be used during pregnancy, unless the doctor finds it necessary and the expected benefit for the mother outweighs the potential risk for the child.
Breast-feeding
Baclofen Aguettant passes into breast milk, but in amounts so small that the infant will probably not experience any undesirable effects. Ask your doctor for advice before using Baclofen Aguettant during breast-feeding.
Some people may feel drowsy and/or dizzy or have problems with their eyes while they are being treated with Baclofen Aguettant. If this happens, you should not drive or do anything that requires you to be alert (such as operate tools or machinery) until these effects have worn off.
This medicine contains 70 mg sodium (main component of cooking/table salt) in each ampoule. This is equivalent to 3.5% of the recommended maximum daily dietary intake of sodium for an adult.
Baclofen Aguettant is administered by intrathecal injection. This means that the medicine is injected directly into the spinal fluid. The dose needed varies from person to person depending on their condition, and the doctor will decide what dose you need after he/ she has tested your response to the drug.
First of all the doctor will find out, by giving you single doses of Baclofen Aguettant, whether it is suitable for you. Usually, this test dose is administered via lumbar puncture or an intrathecal (spinal) catheter, in order to provoke a response. During this period your heart and lung functions will be closely monitored. If your symptoms improve, a special pump which can deliver the drug continuously, will be implanted into your chest or abdominal wall. The doctor will give you all of the information you need to use the pump and to get the correct dosage. Make sure that you understand everything.
The final dose of Baclofen Aguettant depends on how each person responds to the drug. You will be started on a low dose, and this will be increased gradually over a few days, under the supervision of the doctor, until you are having the dose which is right for you. If the starting dose is too high, or if the dose is increased too quickly, you are more likely to experience side effects.
It is extremely important that you keep your appointment with the doctor to refill the pump.
To avoid unpleasant side effects which may be serious and even life-threatening, it is important that your pump does not run out.
The pump must always be filled by a doctor or nurse, and you must make sure that you do not miss your clinic appointments.
Efficacy of baclofen intrathecal has been demonstrated in clinical studies using a pump system to deliver baclofen directly into the spinal fluid (infusion systems). An EU certified pump system is implanted beneath your skin, mostly into the abdominal wall. The pump stores and releases the right amount of medicine through the catheter directly into your spinal fluid.
During long-term treatment some patients find that Baclofen Aguettant becomes less effective. You may require occasional breaks in treatment. Your doctor will advise you what to do.
It is very important that you, and those caring for you, are able to recognise signs of Baclofen Aguettant withdrawal. These signs may appear suddenly or slowly for example because the pump or delivery system is not working properly.
The signs of withdrawal are:
If you have any of the above signs, tell your doctor straight away. These signs may be followed by more serious side effects unless you are treated immediately.
It is very important that you, and anyone caring for you, can recognise the signs of overdose. These may appear if the pump is not working properly, and you must tell the doctor straight away.
Signs of overdose are:
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Baclofen Aguettant can cause side effects, although not everybody gets them.
The side effects listed below have been reported:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Other side effects (how often they happen is not known)
There have been reports of problems associated with the pump and delivery system such as infections, inflammation of the lining around the brain and spinal cord (meningitis) or inflammation at the tip of the delivery tube.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Baclofen Aguettant after the expiry date which is stated on the outer carton and on the ampoule. The expiry date refers to the last day of that month.
Do not refrigerate or freeze.
Store in the original package in order to protect from light.
From a microbiological point of view, unless the method of opening and dilution precludes the risk of microbial contamination, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user.
Do not use Baclofen Aguettant if you notice that the solution is not clear and free from particles.
As it is limited to hospital use the waste drug elimination is carried out directly by the hospital. These measures will help to protect the environment.
Baclofen Aguettant 0.5 mg/ml solution for infusion
1 ampoule with 20 ml of solution contains 10 mg of baclofen.
1 ml of solution for infusion contains 0.5 mg of baclofen.
Solution for infusion
Clear and colorless solution in ampoules.
Baclofen Aguettant 0.5 mg/ml solution for infusion
Type I clear colorless glass 20 ml ampoules with score-break and red colored ring marker.
Box of 1 ampoule containing 20 ml of solution.
Baclofen Aguettant 0.5 mg/ml solution for infusion
Type I clear colorless glass 20 ml ampoules with score-break and red colored ring marker packaged in sterile plastic blister.
Box of 1 ampoule containing 20 ml of solution.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufactured by:
Distributed by:
This leaflet was last revised in 05/2025.
421300411-01
No 1 Farleigh House, Flax Bourton, Old Weston Road, Bristol, BS48 1UR, UK
+44(0)1275 463 691
http://www.aguettant.co.uk
+44(0)1275 463 691
+44(0)1275 463 691